Improved adherence to statin treatment and differences in results between men and women after pictorial risk communication-a sub-study of the VIPVIZA RCT.
Henrik HolmbergEva-Lotta GladerUlf NäslundBo CarlbergEva SönnerstamMargareta NorbergAnders SjälanderPublished in: European journal of clinical pharmacology (2024)
The VIPVIZA study is registered with ClinicalTrials.gov , May 8, 2013, number NCT01849575.